...
首页> 外文期刊>Cancer discovery. >Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations
【24h】

Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations

机译:非编码癌症基因组的出现:基因和表观遗传学改变的目标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The emergence of whole-genome annotation approaches is paving the way for the comprehensive annotation of the human genome across diverse cell and tissue types exposed to various environmental conditions. This has already unmasked the positions of thousands of functional cis-regulatory elements integral to transcriptional regulation, such as enhancers, promoters, and anchors of chromatin interactions that populate the noncoding genome. Recent studies have shown that cis-regulatory elements are commonly the targets of genetic and epigenetic alterations associated with aberrant gene expression in cancer. Here, we review these findings to showcase the contribution of the noncoding genome and its alteration in the development and progression of cancer. We also highlight the opportunities to translate the biological characterization of genetic and epigenetic alterations in the noncoding cancer genome into novel approaches to treat or monitor disease.
机译:全基因组注释方法的出现为人类基因组在暴露于各种环境条件的不同细胞和组织类型中进行全面注释铺平了道路。这已经掩盖了成千上万个转录调控必不可少的顺式调控元件的位置,例如增强子,启动子和填充非编码基因组的染色质相互作用的锚点。最近的研究表明,顺式调控元件通常是与癌症中异常基因表达相关的遗传和表观遗传学改变的靶标。在这里,我们回顾这些发现,以展示非编码基因组的贡献及其在癌症发展和进程中的改变。我们还强调了将非编码癌症基因组中遗传和表观遗传学改变的生物学特征转化为治疗或监测疾病的新方法的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号